FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Indave Sesma Andrea
(Last) (First) (Middle)
C/O FREIGHTOS LIMITED, PLANTA 10
AVDA. DIAGONAL, 211
(Street)
BARCELONA 08018
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Human Resources
3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 07/16/2026   S (1)   199 D $ 1.27 3,602 (2) D  
Ordinary Shares 07/16/2026   S (1)   672 D $ 1.28 14,643 (3) (4) D  
Ordinary Shares 07/16/2026   S (1)   3,795 D $ 1.29 24,205 (5) D  
Ordinary Shares (6)               3,500 D  
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (6) $ 1.45             08/03/2023 11/06/2029 Ordinary Shares 7,476   7,476 D  
Stock Option (right to buy) (6) $ 4.17             01/01/2026 02/17/2032 Ordinary Shares 5,629   5,629 D  
Explanation of Responses:
1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 5,850 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. Such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) are now fully vested and have been settled for underlying ordinary shares. In addition to the 199 shares sold as reported in this row and the 193 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 1,856 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 3,602 ordinary shares are currently held by the Reporting Person from the 5,850 RSUs originally granted.
3. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 19,830 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be fully vested by July 15, 2027.
4. In addition to the 672 shares sold as reported in this row and the 653 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 3,862 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 14,643 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 19,830 RSUs originally granted.
5. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 28,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2025. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date (July 15, 2026), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be fully vested by July 15, 2028.
6. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
Remarks:
Exhibit List: Exhibit 24.1 - Power of Attorney.
/s/ Max Sitnick, Attorney-in-fact 07/20/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EXHIBIT 24.1